Upcoming Key Dates
ROUNDTABLE PROGRAM
Developed by harnessing the expertise of key opinion leaders from ISCT expert committees, ISCT 2025 roundtable sessions provide an interactive platform for in-depth discussions and debates on pivotal subjects including iPSCs, exosomes, CAR-Ts, artificial intelligence, bio-manufacturing and regulatory harmonization.
Join our roundtable sessions to remain well-informed on solutions to the sector's most pressing challenges, engage in conversations propelling the industry forward, and forge connections with potential future collaborators.
Explore ISCT 2025 Roundtable Sessions
ISCT Roundtable Tracks:
TRANSLATIONAL PATHWAY PROGRAM
Immerse yourself in the future of cell and gene therapy with thought-provoking talks and presentations from the most esteemed cell and gene therapy leaders from across the globe.
Sessions will address innovation and groundbreaking research across all stages of product development, from early discovery through to revolutionary approaches that will improve access to CGTs. The Translational Pathway Program is curated by ISCT key opinion leaders to showcase the new developments that will shape the future of our sector.
Explore ISCT 2025 Translational Pathway Program Sessions
Speaker Line Up
ABSTRACTS
Join over 3,000+ international delegates at ISCT 2025 New Orleans to gain unparalleled exposure for your research.
Present and network with decision-makers Including C-Suite, directors, and managers of leading organizations and labs in the global cell and gene therapy space.
Submission Information
Presentation Information
TRAINING & WORKSHOPS
Join us for the 1-day, in-person CGT Immune Monitoring & Immunobiology Education Workshop, designed for advanced practice professionals, clinicians, clinical scientists, and medical students involved in conducting CGT clinical trials or post-therapy patient follow-up.
Learn from renowned immunologists as they share advanced insights and considerations on immune monitoring, novel biomarkers and assays, as well as strategies to standardize and harmonize immune monitoring workflows for better data comparability and patient outcomes.
Learn More about the Immune Monitoring Workshop
Also, gain advanced knowledge to optimize and standardize cell manufacturing processes in the Cell Therapy Manufacturing: Strategy & Optimization course, hosted in ISCT 2025 New Orleans.
This 1-day, in-person training course addresses critical areas within the cell manufacturing workflow where inconsistencies and challenges arise, with real-world case studies presented by leading academic and industry experts.
Learn More about the Cell Therapy Manufacturing Course
CORPORATE SESSIONS
Curate your own 60- or 90-minute session within the ISCT 2025 Main Program. Seize the opportunity to shape the discourse, discuss emerging trends, and establish thought leadership amongst peers and competitors.
GLOBAL SHOWCASE PRESENTATIONS
Pitch your company offerings or share new corporate development activities to engage with partners and customers via a Global Showcase Presentation. Located within the ISCT 2025 Exhibit Hall, the Global Showcase Theatre provides an intimate opportunity to present to meeting attendees.
More Information on Remaining Opportunities
INNOVATION ZONE
The 2025 Innovation Zone is a dedicated space within the ISCT 2025 exhibit hall where disruptive early-stage cell and gene companies can showcase their technology to over 2700+ cell and gene therapy (CGT) translation experts. This space offers an affordable and accessible opportunity for thriving start ups to exhibit alongside leading global CGT organizations.
More Information on How to Participate
ISCT Global Regulators Summit
Optimizing Accelerated Pathways to Fast-Track Product Approvals
Tuesday, May 7, 2025 • Closed, Invitation-Only Event
The 3rd Annual Global Regulators Summit will bring together representatives from international regulatory organizations to jointly address and enhance accelerated regulatory pathways for cell and gene therapy products. The discussion will focus on the evolving regulatory landscape, challenges, and the future directions for accelerated pathways.
The summit will address:
The unprecedented event in 2024 brought together key regulatory leaders and experts from 19 global regulatory agencies and government organizations to address and enhance understanding of global regulatory challenges in the development, manufacture, and accessibility of cell and gene therapy products for treating rare diseases while also discussing current global policies and strategies. Agencies and organizations included DOH (United Arab Emirates), EDQM (EU), CAT-EMA (EU), MHRA (United Kingdom), NoMA (Norway), SAM (Estonia), SFDA (Saudi Arabia), Swissmedic (Switzerland), CBER-FDA (USA), Health Canada, British Columbia Provincial MoH (Canada), CDE (Taiwan), HSA (Singapore), ICMR (India), NPRA (Malaysia), PMDA (Japan), TFDA (Taiwan), TGA (Australia), and ISPCH (Chile).
ISCT Commercialization Signature Series
The ISCT Commercialization Signature Series is an exclusive, industry-driven event that brings together top experts from across the commercialization pipeline to tackle obstacles hindering the sectors growth.
Curated by ISCT Industry Leaders, the 2025 CSS program will focus on enhancing efficiencies and driving innovation in process and manufacturing, to accelerate patient access to transformative CGT therapies. Sessions will address existing bottlenecks in industrialization by debating the need for specialized CGT tools and technologies, the role of PAT and AI-driven analytics, and the industry's influence on evolving regulatory expectations.
Industry experts, regulatory authorities, and CGT pioneers will all be in attendance, working to collaborate on actionable solutions that reduce time-to-market and advance the field at scale.
ISCT Scientific Signature Series
Saturday, May 10, 2025 • Separate Registration Required
The ISCT Scientific Signature Series offers the unique opportunity to connect global Key Opinion Leaders in a chosen scientific field to discuss and deliberate the current state of the art and develop a roadmap to progress the sector.
These events leverage ISCT’s depth and breadth of expertise across academia, industry, and regulation, to drive thought leadership and build collaboration to progress cell and gene therapy (CGT) products to patients globally.
LEARN MORE ABOUT THE EXOSOMES SIGNATURE SERIES
LEARN MORE ABOUT THE iPSC SIGNATURE SERIES
Exhibit Hall
Explore the latest CGT innovations in the ISCT 2025 Exhibit Hall featuring over 150+ international companies.
Conference & Partnering Platform
Access our exclusive platform with access to over 3,000 international delegates to book meetings with future collaborators.
Gala
Join us for a night of celebration in the New Orleans spirit of Mardi Gras for networking like no other.
5K Run
Lace up your running shoes and join us for 'Run the Mississippi' down the iconic Mississippi River.